Want to join the conversation?
$AA 2Q15 Call – William, CFO: Overhead costs continue to decline both sequentially and YoverY. YonY EBITDA improved to $166MM, up 21% over 2Q14. Effective tax rate was 27%. 2Q15 adjusted earnings of $250MM were up 16% over 2Q14. We delivered $209MM after tax productivity gains across all of our segments.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?